TP53 and hepatocellular carcinoma: Among the included studies, 584 cases of p53 gene mutations and 765 cases of p53 protein overexpression were found in HCC tissues, with an average mutation and overexpression prevalence of 35.2% (range 2.9% to 60.7%) and 46.1% (range 5.0% to 72.7%), respectively.